D.E. Shaw & Co
SNTI icon

D.E. Shaw & Co’s Senti Biosciences Holdings SNTI Stock Holding History

D.E. Shaw & Co’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,942
Closed -$1.48M – 5748
2022
Q1 		$1.48M Sell
14,942
-4,427
-23% -$437K ﹤0.01% 3587
2021
Q4 		$1.91M Buy
19,369
+5,607
+41% +$559K ﹤0.01% 3392
2021
Q3 		$1.37M Buy
+13,762
New +$1.36M ﹤0.01% 3358

Other funds holding SNTI

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
FMN
Financial Management Network Mission Viejo, California $653M AUM 17.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
KC
Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return

D.E. Shaw & Co's SNTI Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Senti Biosciences Holdings (SNTI) in Q2 2022, closing a stake of 14,942 shares — an estimated $1.48M sold.

D.E. Shaw & Co first reported a position in SNTI in Q3 2021 and held it in 3 quarters. The position peaked at $1.91M in Q4 2021. 22 funds tracked by Wall St. Rank hold SNTI as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Senti Biosciences Holdings position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,942 Senti Biosciences Holdings shares in Q2 2022, an estimated $1.48M.
  • D.E. Shaw & Co first reported a position in Senti Biosciences Holdings in Q3 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's Senti Biosciences Holdings position peaked at $1.91M in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.